Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Trulieve Cannabis Corp. (TCNNF)
Quincy, FL, US
Trulieve Cannabis Corporation, along with its various subsidiaries, functions as a prominent medical marijuana enterprise. This company manages the entire production cycle, from cultivating its own cannabis to manufacturing finished goods in-house. Its products are then distributed directly to consumers through Trulieve-branded dispensaries located in Florida, with the added convenience of home delivery services within the state. Trulieve boasts a wide array of cannabis product types, including traditional flower, edibles, vaporizer cartridges, concentrates, topical applications, capsules, tinctures, dissolvable powders, and even nasal sprays. These are offered under several proprietary brands, such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One. As of March 16, 2022, the company's retail presence included 162 dispensaries across multiple states. This network comprised 113 stores in Florida, 19 affiliated locations in Pennsylvania, 17 in Arizona, 5 in California, 3 in Maryland, 2 each in Massachusetts and West Virginia, and one in Connecticut. Beyond retail, Trulieve Cannabis Corp. also operates cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. Tracing its origins back to an incorporation in 1940, the company was initially known as Schyan Exploration Inc./Exploration Schyan Inc. It officially adopted the name Trulieve Cannabis Corp. in September 2018 and maintains its headquarters in Quincy, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
102.82M
est: 100.22M (+2.6%)
|
252.82M
est: 252.13M (+0.3%)
|
521.53M
est: 515.24M (+1.2%)
|
938.39M
est: 937.10M (+0.1%)
|
1.24B
est: 1.25B (-0.5%)
|
1.13B
est: 1.11B (+1.5%)
|
1.19B
est: 1.18B (+0.7%)
|
1.20B
est: 1.19B (+1.3%)
|
1.12B
1.05B – 1.24B
-5.9% YoY
|
1.12B
1.01B – 1.40B
+0.7% YoY
|
1.22B
1.13B – 1.44B
+8.8% YoY
|
1.26B
1.16B – 1.48B
+2.9% YoY
|
1.30B
1.19B – 1.52B
+3.1% YoY
|
| EBITDA |
38.25M
est: 21.71M (+76.2%)
|
128.54M
est: 54.61M (+135.4%)
|
207.87M
est: 111.61M (+86.3%)
|
283.59M
est: 202.99M (+39.7%)
|
239.75M
est: 269.87M (-11.2%)
|
-33.06M
est: 241.08M (-113.7%)
|
258.86M
est: 226.72M (+14.2%)
|
334.08M
est: 228.36M (+46.3%)
|
215.00M
201.58M – 239.39M
-5.9% YoY
|
216.45M
195.09M – 268.60M
+0.7% YoY
|
235.42M
216.61M – 276.58M
+8.8% YoY
|
242.25M
222.90M – 284.61M
+2.9% YoY
|
249.83M
229.88M – 293.52M
+3.1% YoY
|
| EBIT |
38.25M
est: 10.05M (+280.6%)
|
112.73M
est: 25.29M (+345.8%)
|
177.69M
est: 51.67M (+243.9%)
|
205.37M
est: 93.98M (+118.5%)
|
54.18M
est: 124.95M (-56.6%)
|
-202.97M
est: 111.62M (-281.8%)
|
92.49M
est: 68.77M (+34.5%)
|
157.64M
est: 69.26M (+127.6%)
|
65.21M
61.14M – 72.61M
-5.9% YoY
|
65.65M
59.17M – 81.47M
+0.7% YoY
|
71.40M
65.70M – 83.89M
+8.8% YoY
|
73.48M
67.61M – 86.33M
+2.9% YoY
|
75.78M
69.72M – 89.03M
+3.1% YoY
|
| Net Income |
42.97M
est: 66.16M (-35.1%)
|
178.03M
est: 259.15M (-31.3%)
|
63.00M
est: 91.04M (-30.8%)
|
18.03M
est: 161.80M (-88.9%)
|
-205.10M
est: -165.14M (-24.2%)
|
-526.80M
est: -393.73M (-33.8%)
|
-155.11M
est: -128.79M (-20.4%)
|
-118.42M
est: -82.30M (-43.9%)
|
27.55M
2.67M – 42.66M
+133.5% YoY
|
59.69M
19.70M – 99.68M
+116.7% YoY
|
53.57M
48.01M – 65.75M
-10.3% YoY
|
65.05M
58.29M – 79.84M
+21.4% YoY
|
76.53M
68.58M – 93.93M
+17.6% YoY
|
| SGA |
29.19M
est: 35.55M (-17.9%)
|
68.01M
est: 89.42M (-24.0%)
|
155.45M
est: 182.74M (-14.9%)
|
315.72M
est: 332.37M (-5.0%)
|
454.60M
est: 441.87M (+2.9%)
|
386.16M
est: 394.74M (-2.2%)
|
510.45M
est: 434.24M (+17.6%)
|
442.36M
est: 437.37M (+1.1%)
|
411.78M
386.08M – 458.50M
-5.9% YoY
|
414.56M
373.66M – 514.45M
+0.7% YoY
|
450.89M
414.88M – 529.74M
+8.8% YoY
|
463.98M
426.92M – 545.12M
+2.9% YoY
|
478.50M
440.28M – 562.19M
+3.1% YoY
|
| EPS |
0.42
est: 0.35 (+20.6%)
|
1.62
est: 1.36 (+18.8%)
|
0.55
est: 0.48 (+14.8%)
|
0.13
est: 0.85 (-84.7%)
|
-1.10
est: -0.87 (-26.6%)
|
-2.84
est: -2.07 (-37.0%)
|
-0.82
est: -0.67 (-21.8%)
|
-0.62
est: -0.43 (-44.1%)
|
0.14
0.01 – 0.22
+133.5% YoY
|
0.31
0.10 – 0.52
+116.7% YoY
|
0.28
0.25 – 0.34
-10.3% YoY
|
0.34
0.30 – 0.42
+21.4% YoY
|
0.40
0.36 – 0.49
+17.6% YoY
|
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TCNNF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
